Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
- 11 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 50 (1), 221-222
- https://doi.org/10.1007/s11239-020-02131-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysisClinica Chimica Acta; International Journal of Clinical Chemistry, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and FollowJournal of the American College of Cardiology, 2020
- COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory FailureThrombosis and Haemostasis, 2020
- Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19Journal of Thrombosis and Haemostasis, 2020
- Response to 'What does monitoring platelet counts in COVID‐19 teach us?'Journal of Thrombosis and Haemostasis, 2020
- Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanationsJournal of Vascular Surgery. Venous and Lymphatic Disorders, 2020
- Thrombocytopenia and its association with mortality in patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Catheter-directed therapy as a first-line treatment strategy in hemodynamically unstable patients with acute pulmonary embolism: Yes or no?International Journal of Cardiology, 2016
- Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarctionJournal of the American College of Cardiology, 1994